Pathos AI Announces Collaborations With Bristol Myers Squibb and Tempus AI

Pathos AI said the multi-year collaborations will build a specialized, curated dataset and agentic AI capabilities for drug development, beginning with Alzheimer’s disease and other neurological conditions.